China companies try to list in US in test for regulators after clampdown
少数中国企业仍试图赴美上市
A handful of companies are seeking to become the first China-headquartered businesses to go public in the US since July, in a test of regulators’ willingness to accept new listings after clampdowns on both sides of the Pacific.
几家公司正寻求成为自去年7月以来首批在美国上市的总部位于中国的企业。在美中监管机构都对在美上市中国企业采取行动后，此举将考验监管机构接受新上市的意愿。
Six China and Hong Kong-based groups filed new or updated documents with the US Securities and Exchange Commission for an initial public offering on the Nasdaq exchange in January. They were followed last week by Meihua International Medical Technologies, a producer of disposable medical devices, which set a target offering price after submitting its initial filing almost six months ago.
总部位于中国内地或香港的六家集团1月向美国证交会(SEC)提交了新文件或更新版文件，申请在纳斯达克(Nasdaq)进行首次公开发行(IPO)。上周, 近六个月前提交初始申请的一次性医疗器械生产商——美华国际医疗科技公司(Meihua International Medical Technologies)紧随其后，设定了目标发行价。
Although each deal is expected to be small in size, lawyers, exchange officials and China experts will be watching them closely for signs that there is still a future for the once-thriving market for Chinese listings.
尽管这些交易的规模预计都较小，但律师、交易所官员和中国专家将密切关注它们，看看曾经热闹的中企赴美上市市场是否仍有一个未来。
